Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats

Pharmacology Biochemistry and Behavior

Volumn 107, Issue , 2013, Pages 29-35

  Méndez Díaz, Mónica ^a   Caynas Rojas, Seraid ^a   Arteaga Santacruz, Vianney ^a   Ruiz Contreras, Alejandra E ^b   Aguilar Roblero, Raúl ^b   Prospéro García, Oscar ^a  

^a UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Anxiety; Cannabinoids; Depression; Globus pallidus; Mood disorders

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ANANDAMIDE; CANNABINOID 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; CONTROLLED STUDY; DEPRESSION; ENTOPEDUNCULAR NUCLEUS; FORCED SWIMMING TEST; MALE; MAZE TEST; MOOD; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; REM SLEEP; SLEEP WAKING CYCLE;

AFFECT; ANIMALS; CANNABINOID RECEPTOR AGONISTS; ENDOCANNABINOIDS; ENTOPEDUNCULAR NUCLEUS; IMMOBILITY RESPONSE, TONIC; MALE; MAZE LEARNING; MICROINJECTIONS; PIPERIDINES; PYRAZOLES; RATS; RECEPTOR, CANNABINOID, CB1; ROTAROD PERFORMANCE TEST; SLEEP; SLEEP STAGES; WAKEFULNESS;

RATTUS;

EID: 84877046094     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2013.04.003     Document Type: Article

References (44)

1. M.T. Alsuwaidan, A. Kucyi, C.W. Law, and R.S. McIntyre Exercise and bipolar disorder: a review of neurobiological mediators Neuromolecular Med 11 2009 328 336
2. C.H. Ashton, and P.B. Moore Endocannabinoid system dysfunction in mood and related disorders Acta Psychiatr Scand 124 2011 250 261
3. S.M. Assadi, M. Yücel, and C. Pantelis Dopamine modulates neural networks involved in effort-based decision-making Neurosci Biobehav Rev 33 2009 383 393
4. H. Atalay Comorbidity of insomnia detected by the Pittsburgh sleep quality index with anxiety, depression and personality disorders Isr J Psychiatry Relat Sci 48 2011 54 59
5. C. Augner Associations of subjective sleep quality with depression score, anxiety, physical symptoms and sleep onset latency in students Cent Eur J Public Health 19 2011 115 117
6. F.R. Bambico, T. Cassano, S. Dominguez-Lopez, N. Katz, C.D. Walker, and D. Piomelli Genetic deletion of fatty acid amide hydrolase alters emotional behavior and serotonergic transmission in the dorsal raphe, prefrontal cortex, and hippocampus Neuropsychopharmacology 35 2010 2083 2100
7. P.J. Batterham, N. Glozier, and H. Christensen Sleep disturbance, personality and the onset of depression and anxiety: prospective cohort study Aust N Z J Psychiatry 2012 10.1177/0004867412457997
8. C.A. Brown, M.C. Campbell, M. Karimi, S.D. Tabbal, S.K. Loftin, and L.L. Tian Dopamine pathway loss in nucleus accumbens and ventral tegmental area predicts apathetic behavior in MPTP-lesioned monkeys Exp Neurol 236 2012 190 197
9. A. Busquets-Garcia, E. Puighermanal, A. Pastor, R. de la Torre, R. Maldonado, and A. Ozaita Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses Biol Psychiatry 70 2011 479 486
10. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
11. S. Esteban, and J.A. García-Sevilla Effects induced by cannabinoids on monoaminergic systems in the brain and their implications for psychiatric disorders Prog Neuropsychopharmacol Biol Psychiatry 38 2012 78 87
12. M.V. Fogaça, D.C. Aguiar, F.A. Moreira, and F.S. Guimarães The endocannabinoid and endovanilloid systems interact in the rat prelimbic medial prefrontal cortex to control anxiety-like behavior Neuropharmacology 63 2012 202 210
13. M. Gadea-Ciria, H. Stadler, K.G. Lloyd, and G. Bartholini Acetylcholine release within the cat striatum during the sleep-wakefulness cycle Nature 243 1973 518 519
14. S. Gaetani, V. Cuomo, and D. Piomelli Anandamide hydrolysis: a new target for anti-anxiety drugs? Trends Mol Med 9 2003 474 478
15. A. Giuffrida, and A. Seillier New insights on endocannabinoid transmission in psychomotor disorders Prog Neuropsychopharmacol Biol Psychiatry 38 2012 51 58
16. M. Glass, M. Dragunow, and R.L. Faull Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain Neuroscience 77 1997 299 318
17. A. Herrera-Solis, K.G. Vazquez, and O. Prospéro-García Acute and subchronic administration of anandamide or oleamide increases REM sleep in rats Pharmacol Biochem Behav 95 2010 106 112
18. S. Huitron-Resendiz, M. Sanchez-Alavez, D.N. Wills, B.F. Cravatt, and S.J. Henriksen Characterization of the sleep-wake patterns in mice lacking fatty acid amide hydrolase Sleep 27 2004 857 865
19. D. Koethe, I.C. Llenos, J.R. Dulay, C. Hoyer, E.F. Torrey, and F.M. Leweke Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression J Neural Transm 114 2007 1055 1063
20. M. Lazarus, Z.L. Huang, J. Lu, Y. Urade, and J.F. Chen How do the basal ganglia regulate sleep-wake behavior? Trends Neurosci 35 2012 723 732
21. I. Lucki The forced swimming test as a model for core and component behavioral effects of antidepressant drugs Behav Pharmacol 8 1997 523 532
22. R. Mechoulam, and L.A. Parker The endocannabinoid system and the brain Annu Rev Psychol 2012 10.1146/annurev-psych-113011-143739
23. T.A. Mellman Sleep and anxiety disorders Psychiatr Clin North Am 29 2006 1047 1058
24. M. Méndez-Díaz, L. Irwin, M. Gómez-Chavarín, A. Jiménez-Anguiano, R. Cabeza, and E. Murillo-Rodríguez Cortistatin modulates memory evocation in rats Eur J Pharmacol 107 2005 21 28
25. M. Méndez-Díaz, E. Domínguez Martín, M. Pérez Morales, A.E. Ruiz-Contreras, L. Navarro, and O. Prospéro-García The anorexigenic peptide cocaine-and-amphetamine- regulated transcript modulates rem-sleep in rats Neuropeptides 43 2009 499 505
26. E. Murillo-Rodríguez, R. Cabeza, M. Méndez-Díaz, L. Navarro, and O. Prospéro-García Anandamide-induced sleep is blocked by SR141716A, a CB1 receptor antagonist and by U73122, a phospholipase C inhibitor Neuroreport 12 10 2001 2131 2136
27. L. Orio, S. Edwards, O. George, L.H. Parsons, and G.F. Koob A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions J Neurosci 29 2009 4846 4857
28. G. Paxinos, and Ch. Watson The rat brain in stereotaxic coordinates 6th ed. 2007 Elsevier Amsterdam
29. S. Pellow, P. Chopin, S.E. File, and M. Briley Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat J Pharm Pharmacol 37 1985 560 563
30. M. Pérez-Morales, I. Alvarado-Capuleño, A.M. López-Colomé, M. Méndez-Díaz, A.E. Ruiz-Contreras, and O. Prospéro-García Activation of PAR1 in the lateral hypothalamus of rats enhances food intake and REMS through CB1R Neuroreport 23 2012 814 818
31. R.D. Porsolt, M. Le Pichon, and M. Jalfre Depression: a new animal model sensitive to antidepressant treatments Nature 266 1977 730 732
32. M.H. Qiu, R. Vetrivelan, P.M. Fuller, and J. Lu Basal ganglia control of sleep-wake behavior and cortical activation Eur J Neurosci 31 2010 499 507
33. M.E. Rice, J.C. Patel, and S.J. Cragg Dopamine release in the basal ganglia Neuroscience 198 2011 112 137
34. P.E. Rueda-Orozco, E. Soria-Gómez, C.J. Montes-Rodríguez, M. Pérez-Morales, and O. Prospéro-García Intrahippocampal administration of anandamide increases REM sleep Neurosci Lett 473 2010 158 162
35. V. Santucci, J.J. Storme, P. Soubrié, and G. Le Fur Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis Life Sci 58 1996 PL103 PL110
36. A. Serrano, and L.H. Parsons Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors Pharmacol Ther 132 2011 215 241
37. D. Shohamy, C.E. Myers, J. Kalanithi, and M.A. Gluck Basal ganglia and dopamine contributions to probabilistic category learning Neurosci Biobehav Rev 32 2008 219 236
38. B. Sivertsen, P. Salo, A. Mykletun, M. Hysing, S. Pallesen, and S. Krokstad The bidirectional association between depression and insomnia: the HUNT study Psychosom Med 74 2012 758 765
39. I. Svízenská, P. Dubový, and A. Sulcová Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review Pharmacol Biochem Behav 90 2008 501 511
40. L.G. Ungerleider, J. Doyon, and A. Karni Imaging brain plasticity during motor skill learning Neurobiol Learn Mem 78 2002 553 564
41. O. Valverde, and M. Torrens CB1 receptor-deficient mice as a model for depression Neuroscience 204 2012 193 206
42. M.P. Viveros, E.M. Marco, and S.E. File Endocannabinoid system and stress and anxiety responses Pharmacol Biochem Behav 81 2005 331 342
43. A. Wichniak, D. Riemann, A. Kiemen, U. Voderholzer, and W. Jernajczyk Comparison between eye movement latency and REM sleep parameters in major depression Eur Arch Psychiatry Clin Neurosci 250 2000 48 52
44. H.L. Yu, X.Q. Deng, Y.J. Li, Y.C. Li, Z.S. Quan, and X.Y. Sun N-palmitoylethanolamide, an endocannabinoid, exhibits antidepressant effects in the forced swim test and the tail suspension test in mice Pharmacol Rep 63 2011 834 839